Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.
Acta Pharmacol Sin
; 44(9): 1932-1934, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-36944800
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ceftazidime
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2023
Type:
Article
Affiliation country:
China